Program 01

CF & Airway Biology

Residual airway inflammation and resolution biology in the era of CFTR modulators.

Cystic fibrosis

What remains after CFTR correction?

Highly effective CFTR modulators have transformed cystic fibrosis care, but molecular correction does not necessarily erase every downstream inflammatory program. We study residual airway inflammation using patient-derived samples, clinical phenotyping and molecular profiling.

Question 01

Residual inflammation

Which inflammatory states persist despite effective CFTR modulation?

Question 02

Resolution

Are pro-resolving lipid pathways restored, incompletely engaged or uncoupled from clinical improvement?

Question 03

Heterogeneity

Why do people receiving the same therapy show different molecular and clinical responses?